After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleeding
- PMID: 32805167
- DOI: 10.7326/ACPJ202008180-022
After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleeding
Abstract
Bonaca MP, Bauersachs RM, Anand SS, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020;382:1994-2004. 32222135.
Comment on
-
Rivaroxaban in Peripheral Artery Disease after Revascularization.N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28. N Engl J Med. 2020. PMID: 32222135 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical